Literature DB >> 15328012

Nitric oxide synthase activity is required for postsynaptic differentiation of the embryonic neuromuscular junction.

Russell C Schwarte1, Earl W Godfrey.   

Abstract

Agrin, a synapse-organizing protein externalized by motor axons at the neuromuscular junction (NMJ), initiates a signaling cascade in muscle cells leading to aggregation of postsynaptic proteins, including acetylcholine receptors (AChRs). We examined whether nitric oxide synthase (NOS) activity is required for agrin-induced aggregation of postsynaptic AChRs at the embryonic NMJ in vivo and in cultured muscle cells. Inhibition of NOS reduced AChR aggregation at embryonic Xenopus NMJs by 50-90%, whereas overexpression of NOS increased AChR aggregate area 2- to 3-fold at these synapses. NOS inhibitors completely blocked agrin-induced AChR aggregation in cultured embryonic muscle cells. Application of NO donors to muscle cells induced AChR clustering in the absence of agrin. Our results indicate that NOS activity is necessary for postsynaptic differentiation of embryonic NMJs and that NOS is a likely participant in the agrin-MuSK signaling pathway of skeletal muscle cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328012     DOI: 10.1016/j.ydbio.2004.06.003

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  3 in total

1.  Guanylate cyclase and cyclic GMP-dependent protein kinase regulate agrin signaling at the developing neuromuscular junction.

Authors:  Earl W Godfrey; Matthew Longacher; Hannah Neiswender; Russell C Schwarte; Darren D Browning
Journal:  Dev Biol       Date:  2007-04-24       Impact factor: 3.582

2.  Role of nitric oxide in classical conditioning of siphon withdrawal in Aplysia.

Authors:  Igor Antonov; Thomas Ha; Irina Antonova; Leonid L Moroz; Robert D Hawkins
Journal:  J Neurosci       Date:  2007-10-10       Impact factor: 6.167

3.  Effects of nitric oxide on neuromuscular properties of developing zebrafish embryos.

Authors:  Michael Jay; Sophie Bradley; Jonathan Robert McDearmid
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.